Cost Effectiveness and Resource Allocation

Papers
(The median citation count of Cost Effectiveness and Resource Allocation is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Strategies for cost-effectiveness analysis of rehabilitation for older patients with acute heart failure36
The impact and cost-effectiveness of 9-valent human papillomavirus vaccine in adolescent females in Hong Kong27
The direct cost of chronic kidney disease (CKD) reported in Asian countries; a systematic literature review22
Comparison of current relative value unit-based prices and utility between common surgical procedures, including orthopedic surgeries, in South Korea21
Use of real-world evidence to support regulatory decisions on medical devices in China and a unique opportunity to gain accelerated approval in “Boao Lecheng Pilot Zone”21
Promoting the integrated community case management of pneumonia in children under 5 years in Nigeria through the proprietary and patent medicine vendors: a cost-effectiveness analysis19
Factor associated with willingness to pay for prevention of cancer: a study of prostate cancer screening18
Temporal trend of comorbidity and increasing impacts on mortality, length of stay, and hospital costs of first stroke in Tianjin, North of China18
Exploration of an alternative reconstructed individual patient data-based approach for budget impact analysis of anticancer drugs16
An assessment of adherence to the WHO-delineated good manufacturing practice by the pharmaceutical companies in Kabul, Afghanistan16
Comparing methods for handling missing cost and quality of life data in the Early Endovenous Ablation in Venous Ulceration trial15
Can integrated care improve the efficiency of hospitals? Research based on 200 Hospitals in China15
Quantifying the direct cost benefits of vestibular telemetry using the CAVA system to diagnose the causes of dizziness15
Tracking malaria health disbursements by source in Zambia, 2009–2018: an economic modelling study14
Cost-effectiveness analysis of dapagliflozin in the management of heart failure with reduced ejection fraction (HFrEF): a systematic review13
A cost-effectiveness analysis of the combination of serplulimab with chemotherapy for advanced esophageal squamous cell carcinoma: insights from the ASTRUM-007 trial12
Economic evaluation of a leprosy innovation project in Northern Nigeria: cost-effectiveness analysis12
Two decades (1998 to 2018) of collaborative human immunodeficiency virus clinical pharmacology capacity building in a resource constrained setting12
Contextualization of cost-effectiveness evidence from literature for 382 health interventions for the Ethiopian essential health services package revision12
Health system productivity in sub-Saharan Africa: tuberculosis control in high burden countries11
The economic burden of bipolar disorder: a case study in Southern Iran10
In situ breast cancer surgeries in Sweden: lumpectomy or mastectomy?—a cost-effectiveness analysis over a 30-Year period using Markov model10
The appearance and increase in the quantity and proportion of the clinical research coordinator’s service fee in drug clinical trial research fund and its impact on trial quality10
The FLURESP European commission project: cost-effectiveness assessment of ten public health measures against influenza in Italy: is there an interest in COVID-19 pandemic?10
Vaccination distribution by community pharmacists under the COVID-19 vaccine appointment system in Taiwan10
Heterogeneity in health funding and disparities in health outcome: a comparison between high focus and non-high focus states in India9
Real-world effectiveness of a new powered stapling system with gripping surface technology on the intraoperative clinical and economic outcomes of gastrectomy for gastric cancer9
Developing and validating a multi-criteria decision analytic tool to assess the value of cancer clinical trials: evaluating cancer clinical trial value9
Optimal strategies to screen health care workers for COVID-19 in the US: a cost-effectiveness analysis9
Evaluation of an Alternative Learning System for youths at risk of involvement in urban violence in the Philippines9
Costs and cost-effectiveness of HIV counselling and testing modalities in Southern Mozambique9
Population ageing and sustainability of healthcare financing in China8
Cost-effectiveness of cardiac resynchronization therapy plus an implantable cardioverter-defibrillator in patients with heart failure: a systematic review8
Framework for determining the optimal course of action when efficiency and affordability measures differ by perspective in cost-effectiveness analysis—with an illustrative case of HIV treatment in Moz8
Systematic review of the evidence sources applied to cost-effectiveness analyses for older women with primary breast cancer8
The health and economic impact and cost effectiveness of interventions for the prevention and control of overweight and obesity in Kenya: a stakeholder engaged modelling study8
Cost-effectiveness of implant movement analysis in aseptic loosening after hip replacement: a health-economic model8
A review on the evolving environment of medical device real-world evidence regulation on market access in the USA8
Cost-effectiveness analysis of COVID-19 tests in the unified health system8
The role of routine chest radiography after implantable venous access port catheter insertion under the guide of ultrasonography and fluoroscopy8
Valuating the efficiency of social security and healthcare in OECD countries from a sustainable development8
Willingness to pay for cataract surgery and its associated factors in selected medical centers in Urmia, Iran7
Cost-effectiveness of sacituzumab govitecan versus single-agent chemotherapy for metastatic triple-negative breast cancer: a trial-based analysis7
Cost-effectiveness analysis of coronary arteries bypass grafting (CABG) and percutaneous coronary intervention (PCI) through drug stent in iran: a comparative study7
What alternative and innovative domestic methods of healthcare financing can be explored to fix the current claims reimbursement challenges by the National Health Insurance Scheme of Ghana? Perspectiv7
Associations between treatment burden, self-reported treatment qualities, antiretroviral therapy obtainment, and health-related quality of life among Ugandan PLWH7
Title: the impact of a pilot integrated care model on the quality and costs of inpatient care among chinese elderly: a difference-in-difference analysis of repeated cross-sectional data7
Measuring efficiency of public hospitals under the impact of Covid-19: the case of Türkiye7
Health technology assessment in sub-Saharan Africa: a descriptive analysis and narrative synthesis7
Cost-effectiveness analysis of Tocilizumab compared to Adalimumab in the treatment of severe active rheumatoid arthritis in Iran6
The impact of government subsidy programs on equity in health financing6
Tuberculosis prevention, diagnosis, and treatment financial profile during 2006–2021: PART A6
The use of cost-effectiveness analysis for health benefit package design – should countries follow a sectoral, incremental or hybrid approach?6
Economic aspects of prolonged home video-EEG monitoring: a simulation study6
The application of artificial intelligence in health financing: a scoping review6
Cost-effectiveness of high-dose vitamin D supplementation to reduce the occurrence of repeat episodes of pneumonia in children6
Comparative effectiveness and cost evaluation of Risankizumab and Adalimumab in the management of psoriasis: a real-world study in Saudi Arabia6
Medical expenditure for lung cancer in China: a multicenter, hospital-based retrospective survey6
A qualitative study on patient-centered care and perceptions of nurses regarding primary healthcare facilities in Nigeria6
Economic burden of knee joint replacement in Iran6
Loss ratio of the capitation payment unit of the health-promoting entities in Colombia between 2017 and 2021: a financial–actuarial approach6
Implementation of a vascular access specialist team in a tertiary hospital: a cost-benefit analysis6
Pharmacoeconomic analysis of biologics and methotrexate for rheumatoid arthritis from the standpoint of the number needed to treat concept under the Japanese health insurance system5
Comparing swab- and different symptoms-based strategies to ascertain COVID-19 recovery in healthcare workers: a cost-effectiveness analysis5
Powered stapling system with gripping surface technology for pulmonary resection of lung cancer: real-world clinical effectiveness5
Cost-effectiveness analysis of isolation strategies for asymptomatic and mild symptom COVID-19 patients5
Global bibliometric analysis of cost effectiveness analysis in healthcare research from 2013 to 20235
Systematic review of economic evaluations for paediatric pulmonary diseases5
Cost-effectiveness analysis of surgical proximal femur fracture prevention in elderly: a Markov cohort simulation model5
Economic evaluations of non-communicable diseases conducted in Sub-Saharan Africa: a critical review of data sources5
Financial burden of prostate cancer in the Iranian population: a cost of illness and financial risk protection analysis5
One-stage vs two-stage bilateral THA in Lombardy: a cost-effectiveness analysis5
Factors affecting health services strategic purchasing for breast cancer patients: a mixed study in Iran5
Excess healthcare costs of mental disorders in children, adolescents and young adults in the Basque population registry adjusted for socioeconomic status and sex5
Health economic evidence for adjuvant chemotherapy in stage II and III colon cancer: a systematic review5
Correction: One-stage vs two-stage bilateral THA in Lombardy: a cost-effectiveness analysis5
Methodology and results of cost-effectiveness of LDL-C lowering with evolocumab in patients with acute myocardial infarction in China5
The value of admission avoidance: cost-consequence analysis of one-year activity in a consolidated service4
Cost and efficiency analysis in Iranian primary health centers: a micro costing and data envelopment analysis4
Indirect comparison between powered and manual circular staplers for left-sided colorectal anastomoses: clinical and economic outcomes in China4
Clinical and economic benefits of image-guided system in functional endoscopicsinus surgery: a retrospective chart review study in China4
Methodological challenges surrounding QALY estimation for paediatric economic evaluation4
Impact of a diabetes pay-for-performance program on nonincentivized mental disorders: a panel study based on claims database analysis4
Understanding the impact of unequal utilization of medical services on the consumption of resources in hemophilia4
How a thrombectomy service can reduce hospital deficit: a cost-effectiveness study4
Colonoscopy in poorly prepped colons: a cost effectiveness analysis comparing standard of care to a new cleansing technology4
What are the short-term annual cost savings associated with kidney transplantation?4
Cost transferability problems in economic evaluation as a framework for an European health care and social costs database4
Cost-utility analysis of TAVI compared with surgery in patients with severe aortic stenosis at low risk of surgical mortality in the Netherlands4
Association between ethnicity and health knowledge among the floating population in China4
Description of day case costs and tariffs of cataract surgery from a sample of nine European countries4
Assessing the impact of grief on quality of life, work productivity, and health outcomes for parents bereaved from SMA: A study protocol4
A cost-effectiveness evaluation of a dietitian-delivered telephone coaching program during pregnancy for preventing gestational diabetes mellitus4
Exploring the potential cost-effectiveness of a new computerised decision support tool for identifying fetal compromise during monitored term labours: an early health economic model4
Nursing labor supply in Iran: a survey in Shiraz public hospitals in 20224
Cost-effectiveness analysis of robot-assisted gait training in patients with bilateral spastic cerebral palsy4
The impact of media reports on energy and environmental efficiency in China: evidence from modified dynamic DEA with undesirable outputs4
Cost-effectiveness of routine versus indicated antibiotic therapy in the management of severe wasting in children4
A systemmatic literature review on indirect costs of women with breast cancer4
Cost-effectiveness of paclitaxel, doxorubicin, cyclophosphamide and trastuzumab versus docetaxel, cisplatin and trastuzumab in new adjuvant therapy of breast cancer in china4
Cost-utility analysis of transitional care services for older inpatients with chronic obstructive pulmonary disease (COPD) in Korea4
Health economic evaluation of blended collaborative care for older multimorbid heart failure patients: study protocol4
Socioeconomic status and self-rated health in Iran: findings from a general population study3
Cost-effectiveness analysis of a strategy to delay progression to dialysis and death among chronic kidney disease patients in Lima, Peru3
The importance and effectiveness of nutritional counselling in patients with autoimmune thyroid diseases in Poland3
Lymphedema self-care: economic cost savings and opportunities to improve adherence3
Cost-effectiveness thresholds or decision-making threshold: a novel perspective3
Cost-effectiveness analysis of nonoperative management versus open and laparoscopic surgery for uncomplicated acute appendicitis in Colombia3
Correction to: Medical expenses and its determinants in female patients with urological disorder3
INES: Interactive tool for construction and extrapolation of partitioned survival models3
Cost-effectiveness of COVID-19 vaccination in Latin America and the Caribbean: an analysis in Argentina, Brazil, Chile, Colombia, Costa Rica, Mexico, and Peru3
Examination on level of scale efficiency in public hospitals in Tanzania3
Cost-effectiveness analysis of adding durvalumab to chemotherapy as first-line treatment for advanced biliary tract cancer based on the TOPAZ-1 trial3
Cost-utility analysis of treating mild stage normal tension glaucoma by surgery in China: a decision-analytic Markov model3
Overview of the main methods used for estimating catastrophic health expenditure3
Cost-effectiveness of atezolizumab versus pembrolizumab as first-line treatment in PD-L1-positive advanced non-small-cell lung cancer in Spain3
Cost-effectiveness analysis of oral nutritional supplements with nutritional counselling in head and neck cancer patients undergoing radiotherapy3
Cost of illness studies in COVID-19: a scoping review3
Cost-effectiveness analysis of neoadjuvant versus adjuvant chemotherapy for cT2-4N0-1 non-small cell lung cancer patients during initial treatment phase3
Economic evaluation of NALIRIFOX vs. nab-paclitaxel and gemcitabine regimens for first-line treatment of metastatic pancreatic ductal adenocarcinoma from U.S. perspective3
Cost of image-guided percutaneous nephrostomy among cervical cancer patients at Muhimbili National Hospital in Tanzania3
Correction: Cost-effectiveness analysis of digital therapeutics for home-based cardiac rehabilitation for patients with chronic heart failure: model development and data analysis3
An overview of the perspectives used in health economic evaluations3
Market access and value-based pricing of digital health applications in Germany3
Strategies for reducing out of pocket payments in the health system: a scoping review3
Preferences as fairness judgments: a critical review of normative frameworks of preference elicitation and development of an alternative based on constitutional economics3
Cost-effectiveness of left atrial appendage closure for stroke prevention in atrial fibrillation: a systematic review appraising the methodological quality3
Monetary valuation of COVID-19 informal care: caregivers’ willingness to pay and willingness to accept3
Cost-effectiveness of pharmacological therapies for people with Alzheimer’s disease and other dementias: a systematic review and meta-analysis3
Cost-effectiveness of abemaciclib plus endocrine therapy in high-risk HR+/HER2–early breast cancer in China3
The cost-effectiveness of school-based interventions for chronic diseases: a systematic review3
Economic burden of breast cancer: a case of Southern Iran3
Analysis of the gap in PCR monitoring availability for patients with chronic myeloid leukemia in 60 low- and middle-income countries3
Operative vs. conservative treatment of AC-Joint Dislocations Rockwood grade ≥ III -An economical and clinical evaluation-3
Costing the outpatient rehabilitation services: time-driven activity-based costing approach3
Cost per DALY averted in low, middle- and high-income countries: evidence from the global burden of disease study to estimate the cost-effectiveness thresholds3
Cost-effectiveness of integrated disease management for high risk, exacerbation prone, patients with chronic obstructive pulmonary disease in a primary care setting3
The cost-effectiveness of standalone HEPA filtration units for the prevention of airborne SARS CoV-2 transmission2
Impacts of the medical arms race on medical expenses: a public hospital-based study in Shenzhen, China, during 2009–20132
Cost-effectiveness of empagliflozin in patients with type 2 diabetes and established cardiovascular disease in China2
Systematic review of economic evaluations on stereotactic ablative radiotherapy (SABR) compared to other radiotherapy techniques or surgical procedures for early-stage non-small cell lung cancer2
Correction to: Cost-effectiveness evaluation of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine for children in Taiwan2
Successes and challenges of China’s health care reform: a four-decade perspective spanning 1985—20232
Hyperkalemia in chronic kidney disease patients with and without heart failure: an Italian economic modelling study2
Inequalities in health care use among patients with arthritis in China: using Andersen’s Behavioral Model2
A cost-effectiveness analysis of ruxolitinib versus best alternative therapy for patients with steroid-refractory chronic graft-versus-host disease aged > 12 years in Singapore2
Healthcare costs for hospitalized COVID-19 patients in a Japanese university hospital: a cross-sectional study2
Cost-effectiveness of using amyloid positron emission tomography in individuals with mild cognitive impairment2
Health technology assessment of medical devices: current landscape, challenges, and a way forward2
Coverage and distributional benefit–cost of rotavirus vaccine in Uganda: an analysis of routine health facility aggregated data2
Cost-utility analysis of total knee arthroplasty alone and in comparison with post-surgical rehabilitation and conservative treatment in the Republic of Kazakhstan2
Correction to: Economic costs, health-related quality of life outcomes and cost-utility of a physical and psychological group intervention targeted at older adults with neurogenic claudication2
Itemized point cost method in human resource cost accounting in medical service projects2
Cost of the national malaria control program and cost-effectiveness of indoor residual spraying and insecticide-treated bed net interventions in two districts of Madagascar2
Comparison of cost effectiveness between video-assisted thoracoscopic surgery (vats) and open lobectomy: a retrospective study2
Do Health Technology Assessment organisations consider manufacturers’ costs in relation to drug price? A study of reimbursement reports2
Values, challenges, and responses associated with high-priced potential cures: perspectives of diverse stakeholders in South Korea2
The development of day surgery in China and the effectiveness and reflection of day surgery in ophthalmology-specialized hospitals2
Cost-effectiveness analysis of fractional flow reserve versus angiography among patients with coronary artery disease undergoing borderline coronary lesions treatment in Iran2
Cost-utility of vitamin D supplementation to prevent acute respiratory infections in children2
Health system efficiency and equity in ASEAN: an empirical investigation2
What are economic costs and when should they be used in health economic studies?2
Cost-utility analysis of genomic profiling in early breast cancer in Colombia2
Correction: Economic burden of breast cancer: a case of Southern Iran2
Controversies in implementing the exemption policy for the elderly healthcare services in Tanzania: experiences from the priority setting process in two selected districts2
Direct and indirect medical costs of bladder cancer in Iran2
The burden of health expenditure on household impoverishment in Ethiopia: a systematic review and meta-analysis2
The cost-effectiveness of B-type natriuretic peptide-guided care in compared to standard clinical assessment in outpatients with heart failure in Tehran, Iran2
Avoiding health technology assessment: a global survey of reasons for not using health technology assessment in decision making2
Is Aducanumab treatment developed to prevent progression of Alzheimer's disease cost-effective in Turkey?2
0.066259860992432